SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ArQule, Inc. (ARQL)
An SI Board Since April 2003
Posts SubjectMarks Bans Symbol
545 40 0 ARQL
Emcee:  tuck Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
345biohealthinvestor.com Just one person's speculation on adding ARQL to the RArthur Radley-6/3/2007
344emphasis mine...... >> Data from ArQule's Phase 1 Trial with c-Met Inscaram(o)uche-6/2/2007
343Nearly 300,000 shares trading in AH and stock is up to $9.21....hummmmm!!!Arthur Radley-5/31/2007
342I hate the phrase "buying opportunity", but I've never understood tom pope-5/23/2007
341$100M shelf offering filed tonight....probably a down draft tomorrow, but shouldArthur Radley-5/22/2007
340Stock traded down from daily high at the close, but the June 10 options again trArthur Radley-5/21/2007
339biohealthinvestor.com Probably a good suggestion about selling into potential gArthur Radley-5/21/2007
338Flurry of buying in the June 10 call at the close...volume jumped to 222, from 1Arthur Radley-5/18/2007
337A block of 250,000 shares traded early today and stock has moved up. It appears Arthur Radley-5/18/2007
336ThinkEquity Starts ArQule (ARQL) at Buy 2:11 PM EDT May 16, 2007 ThinkEquity PaArthur Radley-5/17/2007
335ArQule Reports First Quarter 2007 Financial Results Thursday May 3, 7:00 am ET mopgcw-5/3/2007
334smallcap.seekingalpha.com ArQule: Biotech SmallCap With Major Potential Posted LJM-5/2/2007
333Nice call (valuation thread), T.D.!!! Rickscaram(o)uche-4/27/2007
332Another nice deal for asia. I think I am finally getting it.kenhott-4/27/2007
331ArQule and Kyowa Hakko Kogyo Sign Exclusive License Agreement in Asia for ARQ 19nigel bates-4/27/2007
330thestreet.com Nice comments about ARQL coming from Feurstein...Arthur Radley-4/7/2007
329Added a few more shares today..volume running ahead of daily norm and Leerink piArthur Radley-4/5/2007
328I took a small position in ARQL yesterday...seems it has a little momentum behinArthur Radley-3/30/2007
327ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met Inhibitor, for Orkeokalani'nui-3/14/2007
326Separation Agreement and General Release This agreement (“Agreement”) is made bscaram(o)uche-2/1/2007
325<reply> recurrence, relapsed, refractory, etc. You are right of course.kenhott-1/16/2007
324Reads like they are just talking about some of the relapsed patients that achievkenhott-1/16/2007
323One of which was obviously that first ovarian scan, TELK. Bad karma.scaram(o)uche-1/16/2007
322Now we know where all of those objective responses that we've read about, foscaram(o)uche-1/16/2007
321>Or is the point here that the PERIOD of prior treatments is extraordinarily former_pgs-1/16/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News